YorkBridge Wealth Partners’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-100
Closed -$18K 955
2017
Q3
$18K Hold
100
0.01% 556
2017
Q2
$10K Buy
+100
New +$8.16K 0.01% 637

YorkBridge Wealth Partners's KITE Position: Q4 2017 in Review

YorkBridge Wealth Partners sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 100 shares — an estimated $18K sold.

YorkBridge Wealth Partners first reported a position in KITE in Q2 2017 and held it in 2 quarters. The position peaked at $18K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • YorkBridge Wealth Partners reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • YorkBridge Wealth Partners sold 100 Kite Pharma, Inc. shares in Q4 2017, an estimated $18K.
  • YorkBridge Wealth Partners first reported a position in Kite Pharma, Inc. in Q2 2017 and held it in 2 quarters.
  • YorkBridge Wealth Partners's Kite Pharma, Inc. position peaked at $18K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on YorkBridge Wealth Partners's 13F filing for Q4 2017, filed 12 Feb 2018.